Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Inducing Immune Quiescence to Prevent HIV Infection in Women (IIQ)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Nairobi
Information provided by (Responsible Party):
Dr. Keith Fowke, University of Manitoba
ClinicalTrials.gov Identifier:
NCT02079077
First received: March 3, 2014
Last updated: May 12, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)